A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study).
BACKGROUND: Patient preferences for treatment can pose problems for the conduct of randomised controlled trials: patients with a preference may refuse participation and thereby potentially compromise external validity. Moreover, randomising patients with a preference may affect treatment efficacy an...
Main Authors: | Mills, N, Metcalfe, C, Ronsmans, C, Davis, M, Lane, J, Sterne, J, Peters, T, Hamdy, F, Neal, D, Donovan, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
by: Rosario, D, et al.
Published: (2008) -
The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
by: Lane, J, et al.
Published: (2004) -
Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.
by: Mills, N, et al.
Published: (2003) -
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
by: Rosario, D, et al.
Published: (2012) -
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
by: Rosario, D, et al.
Published: (2012)